Literature DB >> 4005758

Immune-mediated thrombocytopenia due to an iodinated contrast medium (diatrizoate).

A M Shojania.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4005758      PMCID： PMC1346027     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Severe thrombocytopenia as a result of contrast left ventricular angiography.

Authors:  P Wein; M Handler; K D Chadda
Journal:  Cathet Cardiovasc Diagn       Date:  1982

2.  Acute thrombocytopenia following oral cholecystography with iopanoic acid.

Authors:  F Curradi; G Abbritti; G Agnelli
Journal:  Clin Toxicol       Date:  1981-02       Impact factor: 4.467

3.  [Severe thrombopenia due to a peroral triiodized bile contrast media].

Authors:  A Stacher
Journal:  Wien Klin Wochenschr       Date:  1966-04-22       Impact factor: 1.704

4.  Thrombocytopenic purpura following iopanoic acid ingestion.

Authors:  J K Hysell; J W Hysell; J M Gray
Journal:  JAMA       Date:  1977-01-24       Impact factor: 56.272

5.  Severe thrombocytopenia following oral cholecystography with iocetamic acid.

Authors:  C L Insausti; F Lechin; B van der Dijs
Journal:  Am J Hematol       Date:  1983-05       Impact factor: 10.047
  5 in total
  2 in total

1.  Contrast medium-induced severe thrombocytopenia in patient on maintenance hemodialysis: a case report and literature review.

Authors:  Naoko Takeda; Shin-Ichi Araki; Masami Chin-Kanasaki; Norihisa Osawa; Kazunobu Sawai; Kousuke Yamahara; Mako Yasuda-Yamahara; Shinji Kume; Yukihiro Fujita; Hiroshi Maegawa
Journal:  CEN Case Rep       Date:  2020-04-08

Review 2.  Acute severe thrombocytopenia following non-ionic low-osmolarity intravenous contrast medium injection.

Authors:  Pal Bata; Adam Domonkos Tarnoki; David Laszlo Tarnoki; Evelin Horvath; Viktor Berczi; Ferenc Szalay
Journal:  Korean J Radiol       Date:  2012-06-18       Impact factor: 3.500
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.